As of 2024-10-05, the Intrinsic Value of Bruker Corp (BRKR) is
76.21 USD. This BRKR valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 67.00 USD, the upside of Bruker Corp is
13.70%.
The range of the Intrinsic Value is 51.38 - 137.27 USD
76.21 USD
Intrinsic Value
BRKR Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
51.38 - 137.27 |
76.21 |
13.7% |
| DCF (Growth 10y) |
65.46 - 159.73 |
92.92 |
38.7% |
| DCF (EBITDA 5y) |
106.70 - 130.96 |
122.22 |
82.4% |
| DCF (EBITDA 10y) |
116.33 - 153.67 |
137.48 |
105.2% |
| Fair Value |
54.16 - 54.16 |
54.16 |
-19.17% |
| P/E |
79.59 - 111.36 |
95.59 |
42.7% |
| EV/EBITDA |
54.66 - 106.28 |
81.27 |
21.3% |
| EPV |
7.82 - 13.64 |
10.73 |
-84.0% |
| DDM - Stable |
20.63 - 60.12 |
40.37 |
-39.7% |
| DDM - Multi |
46.18 - 104.40 |
64.01 |
-4.5% |
BRKR Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
10,143.13 |
| Beta |
1.21 |
| Outstanding shares (mil) |
151.39 |
| Enterprise Value (mil) |
12,131.83 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.69% |
| Cost of Debt |
4.25% |
| WACC |
8.94% |